These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients. Metzner KJ; Allers K; Rauch P; Harrer T AIDS; 2007 Mar; 21(6):703-11. PubMed ID: 17413691 [TBL] [Abstract][Full Text] [Related]
8. Comparison of time to undetectable HIV viral load in the first 16 weeks after the start of three and four antiretroviral regimens. Manavi K; Scott G Int J STD AIDS; 2006 Aug; 17(8):522-4. PubMed ID: 16925897 [TBL] [Abstract][Full Text] [Related]
9. Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy. Montoya JL; Iudicello J; Oppenheim HA; Fazeli PL; Potter M; Ma Q; Mills PJ; Ellis RJ; Grant I; Letendre SL; Moore DJ; AIDS; 2017 Mar; 31(6):787-795. PubMed ID: 28099190 [TBL] [Abstract][Full Text] [Related]
10. Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered. Gelman BB Curr HIV/AIDS Rep; 2015 Jun; 12(2):272-9. PubMed ID: 25860316 [TBL] [Abstract][Full Text] [Related]
11. Effect of deworming on disease progression markers in HIV-1-infected pregnant women on antiretroviral therapy: a longitudinal observational study from Rwanda. Ivan E; Crowther NJ; Mutimura E; Rucogoza A; Janssen S; Njunwa KK; Grobusch MP Clin Infect Dis; 2015 Jan; 60(1):135-42. PubMed ID: 25210019 [TBL] [Abstract][Full Text] [Related]
12. Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals. Zoufaly A; Kiepe JG; Hertling S; Hüfner A; Degen O; Feldt T; Schmiedel S; Kurowski M; van Lunzen J HIV Med; 2014 Sep; 15(8):449-57. PubMed ID: 24580846 [TBL] [Abstract][Full Text] [Related]
13. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy. Scott Sutton S; Magagnoli J; Hardin JW Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931 [TBL] [Abstract][Full Text] [Related]
14. ERP evidence of impaired central nervous system function in virally suppressed HIV patients on antiretroviral therapy. Chao LL; Lindgren JA; Flenniken DL; Weiner MW Clin Neurophysiol; 2004 Jul; 115(7):1583-91. PubMed ID: 15203059 [TBL] [Abstract][Full Text] [Related]
15. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery. Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577 [TBL] [Abstract][Full Text] [Related]
16. Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts. Cao W; Mehraj V; Trottier B; Baril JG; Leblanc R; Lebouche B; Cox J; Tremblay C; Lu W; Singer J; Li T; Routy JP; ; Vézina S; Charest L; Milne M; Huchet E; Lavoie S; Friedman J; Duchastel M; Villielm F; Côté P; Potter M; Lessard B; Charron MA; Dufresne S; Turgeon ME; Rouleau D; Labrecque L; Fortin C; de Pokomandy A; Hal-Gagné V; Munoz M; Deligne B; Martel-Laferrière V; Gilmore N; Fletcher M; Szabo J Clin Infect Dis; 2016 Jan; 62(2):250-257. PubMed ID: 26349551 [TBL] [Abstract][Full Text] [Related]
17. White matter micro-structural changes in ART-naive and ART-treated children and adolescents infected with HIV in South Africa. Hoare J; Fouche JP; Phillips N; Joska JA; Paul R; Donald KA; Thomas KG; Stein DJ AIDS; 2015 Sep; 29(14):1793-801. PubMed ID: 26372385 [TBL] [Abstract][Full Text] [Related]
19. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression. Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319 [TBL] [Abstract][Full Text] [Related]
20. Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals. Kalayjian RC; Robertson KR; Albert JM; Fichtenbaum CJ; Brown TT; Taiwo BO; J Acquir Immune Defic Syndr; 2019 Jun; 81(2):e49-e54. PubMed ID: 30939531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]